KERSTEN GEERT R
Known title: Chief Executive OfficerCIK: 0001236030
KERSTEN GEERT R's purchase track record
How the stock did after each of KERSTEN GEERT R's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
4
of 6 since May 8, 2024
Stock higher 6 months later
0%
3 months: 40%
Median 6-month return
-60.5%
3 months: -15.8%
Beat the S&P 500
0%
median -73.0% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/25/2026 | CVM | $138K | pending | pending | — |
| 5/13/2026 | CVM | $479K | +23.3% | pending | — |
| 1/22/2026 | CVM | $200K | -48.4% | -81.4% | +7.2% |
| 12/4/2025 | CVM | $50K | -36.4% | -75.7% | +10.6% |
| 7/25/2025 | CVM | $200K | +11.7% | -28.9% | +8.3% |
| 5/8/2024 | CVM | $42K | -15.8% | -45.3% | +14.3% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| CVM | ▲ Buy | Grant | 2,621 | $5K | 9/30/2026 | View on chart |
| CVM | ▲ Buy | Open Market | 100,000 | $138K | 8/25/2026 | View on chart |
| CVM | ▲ Buy | Grant | 5,192 | $5K | 6/30/2026 | View on chart |
| CVM | ▲ Buy | Open Market | 300,000 | $360K | 5/14/2026 | View on chart |
| CVM | ▲ Buy | Open Market | 100,000 | $119K | 5/13/2026 | View on chart |
| CVM | ▲ Buy | Grant | 1,682 | $5K | 3/31/2026 | View on chart |
| CVM | ▲ Buy | Open Market | 38,023 | $200K | 1/22/2026 | View on chart |
| CVM | ▲ Buy | Grant | 998 | $5K | 12/31/2025 | View on chart |
| CVM | ▲ Buy | Open Market | 8,389 | $50K | 12/4/2025 | View on chart |
| CVM | ▲ Buy | Grant | 570 | $5K | 9/30/2025 | View on chart |
| CVM | ▲ Buy | Open Market | 29,197 | $200K | 7/25/2025 | View on chart |
| CVM | ▲ Buy | Grant | 2,292 | $5K | 6/30/2025 | View on chart |
| CVM | ▲ Buy | Grant | 22,786 | $5K | 3/31/2025 | View on chart |
| CVM | ▲ Buy | Grant | 12,940 | $5K | 12/31/2024 | View on chart |
| CVM | ▲ Buy | Grant | 4,882 | $5K | 9/30/2024 | View on chart |
| CVM | ▲ Buy | Grant | 4,461 | $5K | 6/28/2024 | View on chart |
| CVM | ▲ Buy | Open Market | 30,000 | $42K | 5/8/2024 | View on chart |
| CVM | ▲ Buy | Grant | 2,709 | $5K | 3/29/2024 | View on chart |
| CVM | ▲ Buy | Grant | 1,819 | $5K | 12/29/2023 | View on chart |
| CVM | ▲ Buy | Grant | 3,960 | $5K | 9/29/2023 | View on chart |
| CVM | ▲ Buy | Grant | 2,053 | $5K | 6/30/2023 | View on chart |
| CVM | ▲ Buy | Grant | 2,133 | $5K | 3/31/2023 | View on chart |
| CVM | ▲ Buy | Grant | 1,851 | $4K | 12/30/2022 | View on chart |
| CVM | ▲ Buy | Grant | 1,407 | $4K | 9/30/2022 | View on chart |
| CVM | ▲ Buy | Grant | 966 | $4K | 6/30/2022 | View on chart |
| CVM | ▲ Buy | Grant | 1,106 | $4K | 3/31/2022 | View on chart |
| CVM | ▲ Buy | Grant | 612 | $4K | 12/31/2021 | View on chart |
| CVM | ▲ Buy | Grant | 395 | $4K | 9/30/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
Cel-Sci stock shows high RSI and revenue divergence
Recent data for Cel-Sci Corporation indicates a high RSI reading of 85.6, suggesting the stock may be overbought. The company is also showing a six-month revenue and price divergence. Analysts maintain an average target price of $12.50, which is significantly higher than the current trading levels within the 52-week range.
Cel-Sci stock shows high RSI and revenue divergence. Recent data for Cel-Sci Corporation indicates a high RSI reading of 85.6, suggesting the stock may be overbought. The company is also showing a six-month revenue and price divergence. Analysts maintain an average target price of $12.50, which is significantly higher than the current trading levels within the 52-week range.